MRC1 and colorectal carcinoma: uncovered spatially organized multicellular immune hubs in CRC, identifying a myeloid cell‐attracting hub at the tumor‐luminal interface associated with tissue damage, and an MMR‐deficient‐enriched immune hub characterized by activated T cells, malignant cells, and myeloid cells expressing T cell‐attracting chemokines.[21]